B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sb 220025

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sb 220025, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pd
2 shared targets
isotretinoin
2 shared targets
3345
2 shared targets
gw559768x
2 shared targets
tribromsalan
2 shared targets
iodoquinol
2 shared targets
vactosertib
2 shared targets
tanzisertib
2 shared targets
closantel
2 shared targets
benzbromarone
2 shared targets
Loading evidence profile...

This evidence profile for Sb 220025 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.